Vectura is an England-based pharmaceutical company that develops and commercializes inhaled medicines for the treatment of respiratory diseases.
Business Model:
Revenue: $258.8M
Employees: 501-1,000
Vectura was acquired by
Philip Morris International.
The acquisition happend on 2021-07-09.
Details of the transaction were not public
Address: One Prospect House
City: Chippenham
State: england
Zip: SN14 6FH
Country: GB
Vectura is an England-based pharmaceutical company that develops and commercializes inhaled medicines for the treatment of respiratory diseases.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
8/29/2008
Ticker Symbol:
VEC
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/1998 | Seed Round | 2 | $2.7M |
Friends Ivory &a; Sime Excalibur Fund Managers Excalibur Fund Managers Friends Ivory &a; Sime Excalibur Fund Managers |
11/2002 | Private Equity Round | $0 |
ISIS Capital Management Sitka Partners ISIS Capital Management Sitka Partners |
11/2002 | Private Equity Round | 2 | $11.4M |
Sitka Partners ISIS Capital Management Sitka Partners ISIS Capital Management |
---|
Announced Date | Name | Price |
---|---|---|
3/2016 | SkyePharma | |
3/2014 | Activaero | |
11/2006 | Innovata |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|